Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06315855 · ClinicalTrials.gov registry record · NA

F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)

A NA study of Cancer and Periodontal Diseases, sponsored by Georgetown University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06315855: Recruiting NA study of Cancer and Periodontal Diseases, sponsored by Georgetown University.

NCT06315855 is a NA study of Cancer and Periodontal Diseases that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 100 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06315855, a NA study of Cancer and Periodontal Diseases, is actively recruiting participants, sponsored by Georgetown University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The investigators will conduct a 2-arm 6-month randomized clinical controlled trial to evaluate the effectiveness of an oral Telehealth Intervention (THI) in preventing cancer-related oral complications, improving oral health maintenance and oral health related quality of life, and reducing systemic inflammation compared to Usual Care (UC) among unselected cancer survivors.

Primary Outcome

The World Health Organization Oral Toxicity Scale rates the anatomical, and function aspects of oral mucositis. The severity of oral ulcers and ability to consume food and liquid is reported on a scale of 0 (no presentation of symptoms) to 4 (not able to tolerate food or liquid diet). Higher scores indicate worse oral mucositis symptomology. The PROMS questionnaire: Respondents will indicate their level of oral mucositis symptoms on a sliding scale ranging from no experience of a mucositis-rela

Interventions

  • BEHAVIORAL Telehealth Intervention (THI)

Study Locations (1)

District of Columbia

  • Georgetown Lombardi Office of Minority Health - Washington D.C.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-08-20
Est. Completion 2027-08-25
Phase NA
Georgetown University

227 total trials

What NCT06315855 shows while recruiting

NCT06315855 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Telehealth Intervention (THI) is the first listed.

NCT06315855 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06315855 about?

NCT06315855 is a clinical study titled "F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)". The investigators will conduct a 2-arm 6-month randomized clinical controlled trial to evaluate the effectiveness of an oral Telehealth Intervention (THI) in preventing cancer-related oral complications, improving oral health maintenance and oral health related quality of life, and reducing systemic...

What is the current status of trial NCT06315855?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-20. Estimated completion is 2027-08-25.

What conditions does trial NCT06315855 study?

This clinical trial studies the following conditions: Cancer, Periodontal Diseases, Oral Mucositis.

What interventions are being tested in trial NCT06315855?

The interventions under investigation include: Telehealth Intervention (THI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06315855?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06315855 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06315855's enrollment target sits among peer trials

100 313th of 615 higher than 287 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06315855, the US trial registry maintained by the National Library of Medicine. NCT06315855 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.